SkinBioTherapeutics PLC

NEW
LSE:SBTX (UK)  
£ 0.087 -0.0050 (-5.41%) Sep 17
At Loss
P/B:
2.82
Market Cap:
£ 22.68M ($ 30.38M)
Enterprise V:
£ 20.49M ($ 27.45M)
Volume:
345.98K
Avg Vol (2M):
296.73K
Trade In:
Volume:
345.98K
At Loss
Avg Vol (2M):
296.73K

SkinBioTherapeutics PLC (LSE:SBTX) Dividend

SkinBioTherapeutics PLC (LSE:SBTX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -18.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LSE:SBTX Dividend

Does SkinBioTherapeutics PLC (LSE:SBTX) pay a dividend?

SkinBioTherapeutics PLC (LSE:SBTX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't SkinBioTherapeutics PLC pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. SkinBioTherapeutics PLC has returned capital to shareholders via buybacks at a rate of -18.2% over the past 3 years.

What are dividend-paying alternatives to SkinBioTherapeutics PLC?

For dividend-paying alternatives in SkinBioTherapeutics PLC's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.